127 related articles for article (PubMed ID: 30249899)
21. Comparable molecular alterations in 4-nitroquinoline 1-oxide-induced oral and esophageal cancer in mice and in human esophageal cancer, associated with poor prognosis of patients.
Yang Z; Guan B; Men T; Fujimoto J; Xu X
In Vivo; 2013; 27(4):473-84. PubMed ID: 23812217
[TBL] [Abstract][Full Text] [Related]
22. Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.
Miller A; McLeod L; Alhayyani S; Szczepny A; Watkins DN; Chen W; Enriori P; Ferlin W; Ruwanpura S; Jenkins BJ
Oncogene; 2017 May; 36(21):3059-3066. PubMed ID: 27893707
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis.
Yang Y; Ding L; Hu Q; Xia J; Sun J; Wang X; Xiong H; Gurbani D; Li L; Liu Y; Liu A
Mol Cancer; 2017 Aug; 16(1):141. PubMed ID: 28830450
[TBL] [Abstract][Full Text] [Related]
24. Jak-STAT3 pathway triggers DICER1 for proteasomal degradation by ubiquitin ligase complex of CUL4A(DCAF1) to promote colon cancer development.
Ren W; Shen S; Sun Z; Shu P; Shen X; Bu C; Ai F; Zhang X; Tang A; Tian L; Li G; Li X; Ma J
Cancer Lett; 2016 Jun; 375(2):209-220. PubMed ID: 26965998
[TBL] [Abstract][Full Text] [Related]
25. B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6/signal transducer and activator of transcription 3 pathway activation.
Chen X; Wang L; Wang W; Zhao L; Shan B
Cancer Sci; 2016 Jul; 107(7):944-54. PubMed ID: 27088889
[TBL] [Abstract][Full Text] [Related]
26. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma.
Sugimura K; Miyata H; Tanaka K; Hamano R; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Clin Cancer Res; 2012 Sep; 18(18):5144-53. PubMed ID: 22847808
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-130a enhances the killing ability of natural killer cells against non-small cell lung cancer cells by targeting signal transducers and activators of transcription 3.
Zhou X; Liu S; Liu J; Zhang Z; Mao X; Zhou H
Biochem Biophys Res Commun; 2020 Mar; 523(2):481-486. PubMed ID: 31883616
[TBL] [Abstract][Full Text] [Related]
28. Oroxylin A inhibits colitis-associated carcinogenesis through modulating the IL-6/STAT3 signaling pathway.
Yang X; Zhang F; Wang Y; Cai M; Wang Q; Guo Q; Li Z; Hu R
Inflamm Bowel Dis; 2013 Aug; 19(9):1990-2000. PubMed ID: 23823704
[TBL] [Abstract][Full Text] [Related]
29. STAT3 is involved in esophageal carcinogenesis through regulation of Oct-1.
Wang Z; Zhu S; Shen M; Liu J; Wang M; Li C; Wang Y; Deng A; Mei Q
Carcinogenesis; 2013 Mar; 34(3):678-88. PubMed ID: 23172665
[TBL] [Abstract][Full Text] [Related]
30. Reciprocal regulation of miR-206 and IL-6/STAT3 pathway mediates IL6-induced gefitinib resistance in EGFR-mutant lung cancer cells.
Yang Y; Wang W; Chang H; Han Z; Yu X; Zhang T
J Cell Mol Med; 2019 Nov; 23(11):7331-7341. PubMed ID: 31507089
[TBL] [Abstract][Full Text] [Related]
31. IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.
Chen MF; Kuan FC; Yen TC; Lu MS; Lin PY; Chung YH; Chen WC; Lee KD
Oncotarget; 2014 Sep; 5(18):8716-28. PubMed ID: 25238263
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells.
Xiang S; Dong NG; Liu JP; Wang Y; Shi JW; Wei ZJ; Hu XJ; Gong L
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):615-622. PubMed ID: 24142708
[TBL] [Abstract][Full Text] [Related]
33. MiR-296-5p inhibits cell invasion and migration of esophageal squamous cell carcinoma by downregulating STAT3 signaling.
Wang ZZ; Luo YR; Du J; Yu Y; Yang XZ; Cui YJ; Jin XF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5206-5214. PubMed ID: 31298412
[TBL] [Abstract][Full Text] [Related]
34. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.
Gao SP; Mark KG; Leslie K; Pao W; Motoi N; Gerald WL; Travis WD; Bornmann W; Veach D; Clarkson B; Bromberg JF
J Clin Invest; 2007 Dec; 117(12):3846-56. PubMed ID: 18060032
[TBL] [Abstract][Full Text] [Related]
35. Stat3 inhibits PTPN13 expression in squamous cell lung carcinoma through recruitment of HDAC5.
Han XJ; Xue L; Gong L; Zhu SJ; Yao L; Wang SM; Lan M; Zhang W; Li YH
Biomed Res Int; 2013; 2013():468963. PubMed ID: 24191246
[TBL] [Abstract][Full Text] [Related]
36. Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathway.
Kuang Y; Guo W; Ling J; Xu D; Liao Y; Zhao H; Du X; Wang H; Xu M; Song H; Wang T; Jing B; Li K; Hu M; Wu W; Deng J; Wang Q
Cell Death Dis; 2019 Apr; 10(4):297. PubMed ID: 30931929
[TBL] [Abstract][Full Text] [Related]
37. Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway.
Wang X; Wang Y; Xiao G; Wang J; Zu L; Hao M; Sun X; Fu Y; Hu G; Wang J
Oncotarget; 2016 May; 7(21):30350-64. PubMed ID: 27107418
[TBL] [Abstract][Full Text] [Related]
38. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment.
Kuo IY; Yang YE; Yang PS; Tsai YJ; Tzeng HT; Cheng HC; Kuo WT; Su WC; Chang CP; Wang YC
Theranostics; 2021; 11(14):7029-7044. PubMed ID: 34093869
[No Abstract] [Full Text] [Related]
39. Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways.
Leu CM; Wong FH; Chang C; Huang SF; Hu CP
Oncogene; 2003 Oct; 22(49):7809-18. PubMed ID: 14586407
[TBL] [Abstract][Full Text] [Related]
40. Functional polymorphisms in the IL-10 gene with susceptibility to esophageal, nasopharyngeal, and oral cancers.
Li YF; Yang PZ; Li HF
Cancer Biomark; 2016 Mar; 16(4):641-51. PubMed ID: 27002767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
